DE VITA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 23.148
EU - Europa 6.222
AS - Asia 1.624
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 27
SA - Sud America 20
OC - Oceania 4
Totale 31.086
Nazione #
US - Stati Uniti d'America 22.994
UA - Ucraina 2.469
DE - Germania 990
CN - Cina 926
IT - Italia 835
FI - Finlandia 558
SE - Svezia 491
IE - Irlanda 470
SG - Singapore 261
GB - Regno Unito 191
TR - Turchia 191
CA - Canada 151
VN - Vietnam 79
IN - India 76
FR - Francia 47
IR - Iran 41
CZ - Repubblica Ceca 28
EU - Europa 27
RU - Federazione Russa 26
BE - Belgio 25
TG - Togo 22
NL - Olanda 21
KR - Corea 19
JP - Giappone 15
BR - Brasile 12
PL - Polonia 11
GR - Grecia 9
RO - Romania 9
HK - Hong Kong 8
EG - Egitto 7
ES - Italia 7
ZA - Sudafrica 7
PT - Portogallo 6
CL - Cile 5
EE - Estonia 5
HR - Croazia 4
AT - Austria 3
AU - Australia 3
DK - Danimarca 3
TW - Taiwan 3
AL - Albania 2
CH - Svizzera 2
HU - Ungheria 2
MA - Marocco 2
MX - Messico 2
NO - Norvegia 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CO - Colombia 1
ET - Etiopia 1
ID - Indonesia 1
IL - Israele 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
VE - Venezuela 1
ZM - Zambia 1
Totale 31.086
Città #
Woodbridge 3.780
Ann Arbor 2.593
Fairfield 2.014
Houston 1.953
Jacksonville 1.763
Chandler 1.521
Ashburn 1.018
Wilmington 1.003
Dearborn 966
Seattle 702
Boardman 615
Cambridge 613
Beijing 491
Dublin 467
Princeton 466
Udine 300
Izmir 188
Singapore 185
San Diego 183
Ottawa 129
Ogden 104
Des Moines 92
Norwalk 92
Dong Ket 78
Hefei 56
Nanjing 54
New York 54
Redmond 53
Trieste 47
San Mateo 43
Falls Church 41
Kunming 41
Guangzhou 38
Helsinki 30
Brno 26
Los Angeles 26
Milan 26
Andover 24
Brussels 24
Simi Valley 24
Augusta 22
Lomé 22
Munich 22
Leawood 21
Rome 21
Grafing 20
Nanchang 19
Santa Clara 17
Auburn Hills 16
Fuzhou 16
Washington 16
Ardabil 15
Dallas 15
Jinan 15
Toronto 15
Wuhan 15
London 14
Mumbai 14
Redwood City 14
Amsterdam 13
Monmouth Junction 13
Phoenix 13
Shenyang 13
Hyderabad 12
Shanghai 12
Zhengzhou 12
Saint Louis 10
Warsaw 10
Chengdu 9
Paris 9
Pune 9
Tappahannock 9
Chongqing 8
Hong Kong 8
Tavagnacco 8
Verona 8
Indiana 7
Mountain View 7
Baotou 6
Changsha 6
Edinburgh 6
Frankfurt am Main 6
Hangzhou 6
Harbin 6
Hebei 6
Maserada Sul Piave 6
Saint Petersburg 6
São Paulo 6
Xian 6
Johannesburg 5
New Orleans 5
Sesto Fiorentino 5
Shenzhen 5
Tallinn 5
Venezia 5
Zanjan 5
Zero Branco 5
Bologna 4
Buffalo 4
Florence 4
Totale 22.560
Nome #
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients 154
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 153
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 148
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: A nationwide multi-center retrospective observational study 140
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. 139
Terapia dell'artrite reumatoide con immunoglobuline per via endovenosa ad alte dosi: esperienza clinica e revisione della letteratura 139
Validation of the classification criteria for cryoglobulinaemic vasculitis. 138
Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study 138
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 136
Absence of human parvovirus B19 DNA in myoepithelial sialadenitis of primary Sjögren's syndrome. 135
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 135
B-cell lymphomas associated with HCV infection 134
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 131
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 130
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts 130
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 127
Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma 127
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 125
Efficacy and safety of rituximab in type II mixed cryoglobulinemia. 125
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 124
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. 124
Use of teriparatide in osteoporosis due to active rheumatic diseases 122
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 119
Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. 119
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 119
Misoprostol-induced urinary incontinence 117
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 117
Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer 116
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 116
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 116
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 115
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 115
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 115
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 114
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 114
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 114
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 114
Subtypes of Epstein-Barr virus in HIV-1-associated and HIV-1-unrelated Hodgkin's disease cases. 113
Plasmocitoma micromolecolare osteosclerotico 112
Rarity of microsatellite genomic instability in B-cell non-Hodgkin's lymphomas in hepatitis C virus-infected patients 112
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 111
Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. 111
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. 111
BLyS and April serum levels in patients with autoimmune thyroid diseases. 111
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 111
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 111
Medical data quality assessment: On the development of an automated framework for medical data curation 111
Frequent detection of human herpesvirus 6 DNA in HIV-associated lymphadenopathy. 110
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 110
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 110
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 110
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 110
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 109
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 109
Multifocal ischemic necrosis of bone in scleroderma. 108
Leflunomide for active rheumatoid arthritis 108
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 108
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 107
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 107
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 107
Classification of cryoglobulinemic vasculitis 106
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 106
B cell driving cytokines in eraly rheumatoid arthritis. Assessment of possibile clonal expansions during treatment with cyclosporin A. Arthritis and Rheumatism 1996; 39 (Suppl.): S26. 105
Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. 105
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 103
SALIVARY GLAND ECHOGRAPHY IN PRIMARY AND SECONDARY SJOGREN'S SYNDROME 103
Rituximab for the treatment of type II mixed cryoglobulinemia. 103
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 103
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 102
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 102
General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus 101
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 101
Gastrointestinal Involvement in Systemic Vasculitis 101
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 100
Book review: L'actualité rhumatologique 1990 présentée au praticien 99
Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. . 99
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 99
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 98
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus 98
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). 97
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 97
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 97
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 97
Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. 96
Clinical differences between ANA/anti-ENA positive or negative primary Sjögren's syndrome 96
Combinad therapy with cyclobenzaprina and ipuprofen in primary fibromialgia sindrome 96
Emerging drugs for primary Sjögren’s syndrome 96
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 96
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 95
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 95
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 95
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 95
HEPATITIS C VIRUS-RELATED HEPATOCELLULAR CARCINOMA AND B-CELL LYMPHOMA PATIENTS SHOW A DIFFERENT PROFILE OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II ALLELES 95
Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. 94
Characteristics of EBV-infected cells in HIV-related lymphadenopathy: implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals. 94
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 94
True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. 93
Physical training effects in renal transplant recipients. 93
Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue 93
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 93
Totale 11.152
Categoria #
all - tutte 113.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.500 0 0 196 940 492 1.308 783 868 458 719 169 567
2020/20214.606 137 536 87 543 103 580 126 529 924 139 663 239
2021/20223.523 89 403 162 380 108 105 156 232 48 532 673 635
2022/20233.839 515 167 69 427 393 1.043 33 287 574 56 114 161
2023/20241.238 179 120 47 26 223 190 51 93 168 67 24 50
2024/2025976 202 606 168 0 0 0 0 0 0 0 0 0
Totale 31.943